---
title: "KYTX.US (KYTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KYTX.US/news.md"
symbol: "KYTX.US"
name: "KYTX.US"
parent: "https://longbridge.com/en/quote/KYTX.US.md"
datetime: "2026-05-21T02:06:40.450Z"
locales:
  - [en](https://longbridge.com/en/quote/KYTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KYTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KYTX.US/news.md)
---

# KYTX.US (KYTX.US) — Related News

### [CAR-T Welcomes a New Era](https://longbridge.com/en/news/286999381.md)
*2026-05-20T03:28:00.000Z*
> The CAR-T industry welcomes a new landmark event, as Kyverna submitted a Biologics License Application for KYV-101 to th

### [](https://longbridge.com/en/news/286818680.md)
*2026-05-18T20:59:39.000Z*
> The Nasdaq Biotechnology Index closed down 1.85%. Among its components, Gossamer Bio fell 43.29%, Design Therapeutics dr

### [Wells Fargo Remains a Buy on Kyverna Therapeutics, Inc. (KYTX)](https://longbridge.com/en/news/286234948.md)
*2026-05-13T09:38:27.000Z*
> Wells Fargo analyst Derek Archila has maintained a Buy rating on Kyverna Therapeutics, Inc. (KYTX) with a price target o

### [Kyverna Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286150993.md)
*2026-05-12T20:17:39.000Z*
### [Kyverna Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286149491.md)
*2026-05-12T20:09:24.000Z*